{"id":"W4367301161","doi":"10.21037/jtd-23-380","title":"A comprehensive clinical evaluation of first-line drugs for ALK-positive advanced non-small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Journal of Thoracic Disease","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Jiangsu Pharmaceutical Association","keywords":"Alectinib; Crizotinib; Ceritinib; Medicine; Anaplastic lymphoma kinase; Guideline; Lung cancer; Intensive care medicine; Oncology; Internal medicine; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005171363,0.0001255774,0.0004032156,0.000156712,0.00006845608,0.000009693581,0.00007449625,0.00004421359,0.0000482725],"category_scores_gemma":[0.0002149494,0.00009661217,0.0003718839,0.0002386949,0.0000419573,0.0001101657,0.00002204952,0.0001180225,0.000003635868],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000207211,"about_ca_system_score_gemma":0.001034767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001136804,"about_ca_topic_score_gemma":0.000005814699,"domain_scores_codex":[0.9984966,0.00008221944,0.000618643,0.0001601086,0.0004789805,0.0001634306],"domain_scores_gemma":[0.9967341,0.0003224229,0.0005798055,0.0001629543,0.001883911,0.0003168486],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02853179,0.006158346,0.2554568,0.009195657,0.005714784,0.0004501874,0.007479109,0.05497775,0.001865086,0.00002658974,0.02760739,0.6025364],"study_design_scores_gemma":[0.03497305,0.003272283,0.7498679,0.007736332,0.03956533,0.0000196579,0.003454493,0.149769,0.004231253,0.001044761,0.005505145,0.0005607564],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910771,0.003431407,0.0009207907,0.002160293,0.0006035252,0.001269433,0.0002633687,0.0000123594,0.0002617611],"genre_scores_gemma":[0.996602,0.0008780587,0.001177034,0.0002367471,0.0003675773,0.0001132568,0.00008400417,0.0000245194,0.0005168077],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6019757,"threshold_uncertainty_score":0.393973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05279907099811555,"score_gpt":0.4804252321738786,"score_spread":0.4276261611757631,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}